Press Announcements > FDA approves drug to treat dangerously low blood pressure

Press Announcements > FDA approves drug to treat dangerously low blood pressure

	The Division of Drug Information (DDI) - serving the public by providing information on human drug products and drug product regulation by FDA

FDA approves drug to treat dangerously low blood pressure

The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.

Blood pressure is the force of blood pushing against the walls of the arteries as the heart pumps out blood. Hypotension is abnormally low blood pressure. Shock is a critical condition in which blood pressure drops so low that the brain, kidneys and other vital organs can't receive enough blood flow to function properly.

Giapreza can cause dangerous blood clots with serious consequences (clots in arteries and veins, including deep venous thrombosis); prophylactic treatment for blood clots should be used.

 For more information, please visit: Giapreza.